For instance, GPX4 inhibitors, which disrupt the antioxidative defenses of cancer cells, have demonstrated differential ferroptosis effects in thyroid cancer models, providing a promising strategy for overcoming drug resistance (77). Here, GPX4 is linked to thyroid cancer.